BioCentury
ARTICLE | Clinical News

PEP-CMV: Phase I/II data

March 16, 2015 7:00 AM UTC

Researchers at Duke University (Durham, N.C.) reported data from a U.S. Phase I/II trial in 12 patients with newly diagnosed GBM showing that preconditioning the vaccine site with a tetanus/diphtheri...